Coherus Oncology Inc.
CHRS | NASDAQ
$1.33
-$0.04 (-2.92%)
Sep 22, 2026, 11:02 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 14.31M | 12.31M | 12.75M | 11.57M | 10.25M | 7.6M | 54.14M | 70.77M | 64.98M | 2.31M | 91.52M | 74.57M | 58.72M | 32.44M | 45.35M | 45.42M | 60.15M | 60.12M | 73.37M | 82.5M | 87.64M | 83.03M |
Cost of Revenue | 4.24M | 4.7M | 4.94M | 4.69M | 4.41M | 3.7M | 33.86M | 20.74M | 29.56M | 1.44M | 84.57M | 32.7M | 24.85M | 16.87M | 14.2M | 35.23M | 11.28M | 9.37M | 12.1M | 21.28M | 16.7M | 7.51M |
Gross Profit | 10.07M | 7.62M | 7.81M | 6.88M | 5.84M | 3.9M | 20.29M | 50.03M | 35.42M | 869K | 6.96M | 41.87M | 33.87M | 15.56M | 31.15M | 10.19M | 48.87M | 50.75M | 61.27M | 61.22M | 70.95M | 75.52M |
Operating Income | -32.33M | -36.15M | -45.88M | -42.23M | -45.49M | -45.44M | -42.25M | -6.39M | -20.51M | -67.79M | -68.91M | -32.01M | -34.54M | -67.75M | -51.49M | -80.45M | -44.01M | -80.93M | -39.55M | -32.79M | -24.16M | -167.36M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -33.35M | -36.94M | -46.35M | -44.52M | -44.86M | -47.4M | -50.7M | -10.75M | -12.92M | -68.04M | -79.65M | -40.02M | -42.87M | -75.73M | -58.87M | -86.65M | -50.15M | -96.08M | -45.73M | -38.53M | -29.9M | -172.95M |
Net Income | -20.63M | -37.94M | -37.28M | -35.11M | -41.34M | -56.57M | -50.7M | -10.75M | -12.92M | 102.88M | -79.65M | -39.64M | -42.87M | -75.73M | -58.87M | -86.65M | -50.15M | -96.08M | -45.73M | -38.53M | -29.9M | -172.95M |
Selling & General & Admin | 20.95M | 23.1M | 23.61M | 22.83M | 26.04M | 26.03M | 41.3M | 34.74M | 35.17M | 40.23M | 49.49M | 48.22M | 45.14M | 49.15M | 53.62M | 44.83M | 51.28M | 48.75M | 50.05M | 39.93M | 40.35M | 39.39M |
Research & Development | 21.44M | 20.66M | 30.08M | 26.29M | 25.29M | 23.31M | 21.24M | 21.68M | 20.77M | 28.42M | 26.37M | 25.65M | 23.27M | 34.15M | 29.02M | 45.81M | 41.61M | 82.92M | 50.76M | 54.09M | 54.77M | 203.49M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 42.4M | 43.77M | 53.69M | 49.12M | 51.33M | 49.34M | 62.53M | 56.42M | 55.93M | 68.66M | 75.86M | 73.87M | 68.41M | 83.31M | 82.64M | 90.64M | 92.89M | 131.67M | 100.81M | 94.01M | 95.11M | 242.88M |
Interest Expense | 2.32M | 2.19M | 2.25M | 2.33M | 2.28M | 2.15M | 5.35M | 5.36M | 5.33M | 11.12M | 10.62M | 10.27M | 9.94M | 9.71M | 9.39M | 7.54M | 6.58M | 8.97M | 5.79M | 5.77M | 5.75M | 5.65M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 46.64M | 48.46M | 58.63M | 53.8M | 55.74M | 53.03M | 96.39M | 77.16M | 85.49M | 70.1M | 160.43M | 106.57M | 93.26M | 100.18M | 96.85M | 125.87M | 104.16M | 141.04M | 112.92M | 115.29M | 111.81M | 250.39M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -380K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 154.82M | 136.4M | 120.37M | 116.23M | 116.08M | 115.86M | 115.42M | 115.21M | 114.82M | 112.75M | 111.49M | 97.74M | 87.27M | 79.27M | 77.96M | 77.75M | 77.15M | 77.25M | 76.35M | 78.63M | 75.56M | 72.83M |
Shares Outstanding (Diluted) | 154.82M | 136.4M | 120.37M | 116.23M | 116.08M | 115.86M | 115.42M | 115.21M | 114.82M | 125.53M | 111.49M | 97.74M | 87.27M | 79.27M | 77.96M | 77.75M | 77.55M | 77.25M | 76.83M | 79.01M | 75.56M | 72.83M |
EPS (Basic) | -0.13 | -0.28 | -0.31 | -0.30 | -0.39 | -0.49 | -0.44 | -0.09 | -0.11 | 0.91 | -0.71 | -0.41 | -0.49 | -0.94 | -0.85 | -1.19 | -0.73 | -1.44 | -0.60 | -0.49 | -0.40 | -2.37 |
EPS (Diluted) | -0.13 | -0.28 | -0.31 | -0.30 | -0.39 | -0.49 | -0.44 | -0.09 | -0.11 | 0.82 | -0.71 | -0.41 | -0.49 | -0.94 | -0.85 | -1.19 | -0.73 | -1.44 | -0.60 | -0.49 | -0.40 | -2.37 |
EBITDA | -31.02M | -33.87M | -43.2M | -41.23M | -41.57M | -44.2M | -44.32M | -3.84M | -6.4M | -63.41M | -67.97M | -28.12M | -32.05M | -65.07M | -48.44M | -78.12M | -42.68M | -86.35M | -39.1M | -31.87M | -23.28M | -166.45M |
EBIT | -31.02M | -34.75M | -44.1M | -42.19M | -42.59M | -45.25M | -45.35M | -5.39M | -7.59M | -64.92M | -69.03M | -29.75M | -32.93M | -66.02M | -49.49M | -79.11M | -43.57M | -87.12M | -39.93M | -32.76M | -24.15M | -167.3M |
Depreciation & Amortization | n/a | 881K | 896K | 966K | 1.02M | 1.05M | 1.03M | 1.55M | 1.19M | 1.51M | 1.06M | 1.64M | 880K | 949K | 1.05M | 995K | 887K | 767K | 836K | 892K | 877K | 849K |
Add to Watchlist
Select watchlists to add or remove CHRS